$1 Billion is the total value of Clarius Group, LLC's 494 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWB | ISHARES TRrus 1000 etf | $7,775,000 | -5.0% | 39,400 | 0.0% | 0.78% | -4.9% | |
SMAR | SMARTSHEET INC | $6,632,000 | +9.3% | 193,023 | 0.0% | 0.66% | +9.6% | |
SUSB | ISHARES TResg awre 1 5 yr | $4,424,000 | -2.5% | 188,337 | 0.0% | 0.44% | -2.4% | |
PI | IMPINJ INC | $3,151,000 | +36.4% | 39,377 | 0.0% | 0.32% | +36.4% | |
TWST | TWIST BIOSCIENCE CORP | $1,749,000 | +0.8% | 49,635 | 0.0% | 0.18% | +1.2% | |
IXUS | ISHARES TRcore msci total | $1,429,000 | -10.7% | 28,057 | 0.0% | 0.14% | -10.6% | |
QQQ | INVESCO QQQ TRunit ser 1 | $1,417,000 | -4.6% | 5,301 | 0.0% | 0.14% | -4.1% | |
BEAM | BEAM THERAPEUTICS INC | $1,339,000 | +23.1% | 28,111 | 0.0% | 0.13% | +22.9% | |
IWD | ISHARES TRrus 1000 val etf | $1,130,000 | -6.1% | 8,306 | 0.0% | 0.11% | -5.8% | |
NAUT | NAUTILUS BIOTECHNOLOGY INC | $1,069,000 | -21.2% | 504,404 | 0.0% | 0.11% | -20.7% | |
FLYW | FLYWIRE CORPORATION | $786,000 | +30.1% | 34,239 | 0.0% | 0.08% | +31.7% | |
QTRX | QUANTERIX CORP | $684,000 | -31.9% | 62,060 | 0.0% | 0.07% | -32.0% | |
REGN | REGENERON PHARMACEUTICALS | $573,000 | +16.5% | 832 | 0.0% | 0.06% | +16.3% | |
VBR | VANGUARD INDEX FDSsm cp val etf | $550,000 | -4.3% | 3,836 | 0.0% | 0.06% | -3.5% | |
QQQJ | INVESCO EXCH TRADED FD TR IInasdaqnxtgen100 | $456,000 | -5.0% | 20,601 | 0.0% | 0.05% | -4.2% | |
VPL | VANGUARD INTL EQUITY INDEX Fftse pacific etf | $465,000 | -9.5% | 8,095 | 0.0% | 0.05% | -9.8% | |
IGM | ISHARES TRexpnd tec sc etf | $450,000 | -6.2% | 1,629 | 0.0% | 0.04% | -6.2% | |
TEAM | ATLASSIAN CORP PLCcl a | $421,000 | +12.3% | 2,000 | 0.0% | 0.04% | +13.5% | |
COLB | COLUMBIA BKG SYS INC | $332,000 | +0.9% | 11,478 | 0.0% | 0.03% | 0.0% | |
REMITLY GLOBAL INC | $307,000 | +45.5% | 27,592 | 0.0% | 0.03% | +47.6% | ||
RXRX | RECURSION PHARMACEUTICALS INcl a | $304,000 | +30.5% | 28,601 | 0.0% | 0.03% | +30.4% | |
FSBW | FS BANCORP INC | $273,000 | -4.9% | 10,000 | 0.0% | 0.03% | -6.9% | |
ILMN | ILLUMINA INC | $269,000 | +3.5% | 1,411 | 0.0% | 0.03% | +3.8% | |
WSO | WATSCO INC | $257,000 | +7.5% | 1,000 | 0.0% | 0.03% | +8.3% | |
CQQQ | INVESCO EXCH TRADED FD TR IIchina technlgy | $258,000 | -27.9% | 7,093 | 0.0% | 0.03% | -27.8% | |
GLD | SPDR GOLD TR | $236,000 | -8.2% | 1,523 | 0.0% | 0.02% | -7.7% | |
FRESHWORKS INC | $197,000 | -1.5% | 15,186 | 0.0% | 0.02% | 0.0% | ||
LYEL | LYELL IMMUNOPHARMA INC | $120,000 | +12.1% | 16,404 | 0.0% | 0.01% | +9.1% | |
ACCD | ACCOLADE INC | $121,000 | +55.1% | 10,585 | 0.0% | 0.01% | +50.0% | |
ATHA | ATHIRA PHARMA INC | $97,000 | -3.0% | 32,825 | 0.0% | 0.01% | 0.0% | |
ABSCI CORPORATION | $94,000 | -6.0% | 30,000 | 0.0% | 0.01% | -10.0% | ||
SANA | SANA BIOTECHNOLOGY INC | $75,000 | -6.2% | 12,500 | 0.0% | 0.01% | -12.5% | |
ZY | ZYMERGEN INC | $54,000 | +125.0% | 19,350 | 0.0% | 0.01% | +150.0% | |
VAXXINITY INC | $40,000 | +29.0% | 20,000 | 0.0% | 0.00% | +33.3% | ||
NLTX | NEOLEUKIN THERAPEUTICS INC | $15,000 | -37.5% | 23,514 | 0.0% | 0.00% | -50.0% | |
RUBY | RUBIUS THERAPEUTICS INC | $10,000 | -47.4% | 22,674 | 0.0% | 0.00% | -50.0% | |
CGEN | COMPUGEN LTDord | $7,000 | -63.2% | 10,000 | 0.0% | 0.00% | -50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-24
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PACCAR INC | 32 | Q3 2023 | 39.5% |
AMAZON INC | 32 | Q3 2023 | 16.5% |
MICROSOFT CORP | 32 | Q3 2023 | 10.8% |
VANGUARD INDEX FDS | 32 | Q3 2023 | 9.8% |
APPLE INC | 32 | Q3 2023 | 3.0% |
VANGUARD INDEX FDS | 32 | Q3 2023 | 4.4% |
STARBUCKS CORP | 32 | Q3 2023 | 5.4% |
ISHARES TR RUS 1000 ETF | 32 | Q3 2023 | 2.9% |
VANGUARD INDEX FDS | 32 | Q3 2023 | 2.6% |
ALPHABET INC | 32 | Q3 2023 | 1.5% |
View Clarius Group, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-17 |
13F-HR | 2024-01-29 |
13F-HR | 2023-10-19 |
13F-HR | 2023-08-10 |
13F-HR | 2023-04-17 |
13F-HR | 2023-01-25 |
13F-HR | 2022-10-24 |
13F-HR | 2022-08-10 |
13F-HR | 2022-04-08 |
13F-HR | 2022-02-02 |
View Clarius Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.